DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Lowered to $23.00 at Morgan Stanley

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price decreased by Morgan Stanley from $30.00 to $23.00 in a report issued on Tuesday,Benzinga reports. Morgan Stanley currently has an overweight rating on the medical instruments supplier’s stock.

XRAY has been the topic of several other reports. Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. StockNews.com lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research note on Friday, November 8th. Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Finally, Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average target price of $27.91.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $19.19 on Tuesday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $3.81 billion, a P/E ratio of -9.28, a PEG ratio of 1.93 and a beta of 0.96. The firm has a fifty day moving average of $21.18 and a 200-day moving average of $24.11. DENTSPLY SIRONA has a 52-week low of $17.21 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 EPS. As a group, analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Stockholders of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date is Friday, December 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.34%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Institutional Trading of DENTSPLY SIRONA

Hedge funds and other institutional investors have recently bought and sold shares of the company. Synovus Financial Corp bought a new position in DENTSPLY SIRONA during the 3rd quarter worth approximately $240,000. Tidal Investments LLC acquired a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $602,000. Wilmington Savings Fund Society FSB bought a new position in DENTSPLY SIRONA during the third quarter worth $261,000. M&T Bank Corp boosted its holdings in DENTSPLY SIRONA by 5.6% in the third quarter. M&T Bank Corp now owns 39,079 shares of the medical instruments supplier’s stock worth $1,058,000 after purchasing an additional 2,062 shares during the period. Finally, Barclays PLC increased its stake in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after purchasing an additional 54,920 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.